Open AccessArticle

Changes in the Expression Profile of Pyroptosis-Related Genes in Senescent Retinal Pigment Epithelial Cells after Lutein Treatment

Barbara Strzalka-Mrozik

^1,*

Marcel Madej

Natalia Kurowska

¹,

Celina Kruszniewska-Rajs

Magdalena Kimsa-Dudek

Jolanta Adamska

¹ and

Joanna Magdalena Gola

Department of Molecular Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 40-055 Katowice, Poland

Department of Nutrigenomics and Bromatology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 40-055 Katowice, Poland

Author to whom correspondence should be addressed.

Curr. Issues Mol. Biol. 2023, 45(2), 1500-1518; https://doi.org/10.3390/cimb45020097

Submission received: 28 December 2022 / Revised: 2 February 2023 / Accepted: 7 February 2023 / Published: 9 February 2023

(This article belongs to the Collection Application of Natural and Pseudo Natural Products in Drug Discovery and Development)

Download

Browse Figures

Figure 1
Cell viability of the ARPE-19 cells that were treated with (a) H2O2 for 30, 60, and 120 min., as well as (b) treated with lutein for 24 h. Each bar represents the mean ± standard deviation (SD), Dunnett’s test, * p < 0.05 versus control (C). Sample size: five wells and three technical replicates for each concetration of H202 and eight wells and three technical replicates for each concetration of lutein. "> Figure 2
Non-treated and H2O2-treated ARPE-19 cells stained for senescence-associated β-galactosidase activity. The cells were treated with H2O2 at a concentration of 400 μM for 60 min. The arrows indicate blue SA-β-gal-positive cells. "> Figure 3
Percentage of SA-β-gal-positive cells in non-treated (C) and H2O2-treated ARPE-19 cells (H). The bars present mean ± standard deviation (SD); Student’s t-test; * p < 0.05. The percent of SA-β-gal-positive cells was counted in ten microscopic fields. "> Figure 4
Changes in the mRNA levels of (a) TP53, (b) CDKN1A and (c) CDKN1B genes in non-treated (C) and H2O2-treated (H) ARPE-19 cells. The box and whisker plots present the mean ± standard error (SE) and standard deviation (SD) of copy numbers per 1 μg of the total RNA; Student’s t-test; * p < 0.05 versus C. Sample size: three biological and three technical replicates for each test group. "> Figure 5
Fluorescence signal intensity maps specific to 128 ID mRNA pyroptosis-related genes specific to the control ARPE--19 cells (C), lutein-treated ARPE-19 cells (L), H2O2--treated ARPE-19 cells (H), and lutein-- and H2O2-treated ARPE-19 cells (LH). Blue—indicates the lowest values and red—indicates the highest values of fluorescence signals. "> Figure 6
Changes in the mRNA levels of (a) TXNIP, (b) CXCL8, (c) BCL2, (d) BAX, (e) CASP1, and (f) CASP9 genes in senescent retinal pigment epithelial cells after treatment with H2O2 (H), lutein (L), co-treated with lutein and H2O2 (LH), and non-treated cells (C). The box and whisker plots present the mean ± standard error (SE) and standard deviation (SD) of copy numbers per 1 μg of the total RNA; Tukey’s post hoc test; * p < 0.05 versus C; # p < 0.05 versus H; ^ p < 0.05 versus LH. Sample size—three biological and three technical replicates for each test group. "> Figure 7
Protein–protein interaction network generated using the STRING database. STRING database—Search Tool for the Retrieval of Interacting Genes/Proteins. ">

Review Reports Versions Notes

Abstract

Retinal pigment epithelium (RPE) is a specialized structure essential for proper vision, which is constantly exposed to oxidative damage. With aging, this damage accumulates within the RPE cells, causing various diseases, including age-related macular degeneration (AMD). Numerous antioxidant substances are used to prevent this process in humans, including lutein. This study aims to determine the differences in the expression patterns of pyroptosis genes in senescent human retinal pigment epithelial cell line ARPE-19 exposed to lutein. Changes in the expression of pyroptosis-related genes were assessed by oligonucleotide microarrays, and the results were validated by real-time RT-qPCR. The microarray analysis showed seven transcripts were differentially expressed both in the H₂O₂-treated cells versus the controls and in the lutein/H₂O₂-treated cells compared to the H₂O₂-treated cells (FC > 2.0). Depending on the used lutein, H₂O₂, or co-treatment of ARPE-19 cells, statistically significant differences in the expression of TXNIP, CXCL8, BAX, and CASP1 genes were confirmed by the RT-qPCR (p < 0.05). A STRING database analysis showed that the proteins encoded by the analyzed genes form a strong interaction network (p < 0.001). These data indicate that lutein modulates the expression level of pyroptosis-related genes, which may be useful for the development of new methods preventing pyroptosis pathway activation in the future.

Keywords:

lutein; pyroptosis; oxidative stress; senescent retinal pigment epithelial cells; genes; expression; oligonucleotide microarray; real-time RT-qPCR

1. Introduction

Aging is a natural process that affects all organisms. With age, both physiological and pathological changes are induced in the human body [1]. In the elderly population, age-related macular degeneration (AMD) is the main cause of irreversible blindness and may lead to a reduction in the quality of life [2].

Published data has demonstrated that the retinal pigment epithelium (RPE) plays a key role in maintaining retinal homeostasis and its dysfunction and degeneration is found in many retinal diseases, including AMD [3]. Bruch’s membrane (BrM) thickness and choroid are also integral to the pathogenesis of AMD [4,5]. The most characteristic feature of this pathology is damage to RPE cells due to the formation and deposition of drusen, while its best understood molecular mechanisms are oxidative stress and inflammation [6]. In fact, the retina is exposed to extremely high oxidative stress that increases with age. Large amounts of reactive oxygen species (ROS) are produced in retinal tissue, making it particularly susceptible to oxidative damage [7]. This is because the highest oxygen consumption among human tissues occurs in the retina. Macular and RPE photoreceptors are subjected to constant exposure to light and ultraviolet radiation. There are many photosensitizers in the RPE and photoreceptors. One of them is the easily oxidized polyunsaturated fatty acids (PUFAs), which are present in large amounts in the photoreceptor cell membrane [6,7]. Damage to RPE cells and photoreceptors is particularly associated with exposure to visible light of a short wavelength, as the lens and cornea mainly absorb UV radiation. In addition, a high retinal oxygen partial pressure of 70 mmHg promotes the formation of ROS [6,7]. With age, ROS levels in the aging retina increase, while at the same time, the activity of antioxidant enzymes, such as glutathione, glutathione S-transferases (GSTs), and superoxide dismutase (SOD), leads to oxidative stress, causing damage to the RPE cells and photoreceptors, as well as their programmed death [6,8].

On the one hand, the accumulation of drusen causes inflammation, and inflammatory cells reaching the retina and RPE cells secrete various growth factors, such as vascular endothelial growth factor (VEGF). This contributes to the growth of blood vessels under the RPE layer and choroidal neovascularization (CNV). Ultimately, these pathological processes turn dry AMD into neovascular AMD and lead to central vision loss [8]. Late-stage AMD is characterized by RPE cell death, resulting in photoreceptor dysfunction [9].

It has been suggested that the pathogenesis of AMD involves oxidative and endoplasmic reticulum (ER) stress, impaired autophagy, mitochondrial dysfunction, and inflammation [10]. RPE is the primary pathological site in AMD, but the mechanism of RPE cell death is still unclear.

In addition to the basic process of apoptosis, recent scientific studies have also identified new types of programmed cell death (PCD), which may lead to RPE cell death in AMD. They are pyroptosis, necroptosis, and ferroptosis [8]. The primary step in pyroptosis is the activation of the NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) inflammasome, leading to the cleavage of gasdermin D (GSDMD) and the activation of the interleukins IL-1β and IL-18 [11]. Furthermore, inflammasomes play a huge role in the molecular mechanism of pyroptosis [12]. The most widely studied inflammasome is the NLRP3 inflammasome [12]. Its activation is triggered by various cellular and molecular events, such as mitochondrial dysfunction, reactive oxygen species production, ion flow, and lysosome damage [13]. Therefore, the activation of the NLRP3 inflammasome has been detected in various disorders, including macular degeneration.

In 2018, Gao et al. [14] investigated the mechanisms of RPE cell death under prolonged amyloid β-induced inflammasome activity. Strong activation of the inflammasome was evident through increased caspase-1 (CASP1) reactivity and increased levels of IL-1β and IL-18 proteins. In RPE cells, cleavage of caspase-3 (CASP3) and GSDMD, markers of both apoptosis and pyroptosis, was observed. In addition, these cells showed morphological features of pyroptosis, including swelling. This evidence suggests the activation of two death pathways in RPE cells: apoptosis and pyroptosis [14]. In another study from 2020, an in vitro model of AMD involving the induction of retinal pigment epithelium 19 (ARPE-19) damage by amyloid β confirmed the involvement of pyroptosis in RPE cell death [15].

Lutein is one of several compounds from the carotenoid group found in the macula of the retina. It is not produced in the body; therefore, it must be obtained from foods such as broccoli, spinach, kale, peas, lettuce, and egg yolk. Moreover, two other types of carotenoids are also present in the macula, namely zeaxanthin (a stereoisomer of lutein that is also obtained from the diet) and meso-zeaxanthin (a metabolite of lutein that is formed at the macula via metabolic transformation) [16]. These carotenoids exhibit regional dominance in the macula, with lutein present at the highest quantity in the periphery, zeaxanthin in the mid-periphery, and meso-zeaxanthin in the epicenter, respectively [17]. In fact, lutein shows antioxidant activity and functions as a blue light filter, making it one of the greatest allies in the fight against eye diseases. Furthermore, it has anti-inflammatory properties, reduces VEGF expression, and has a limiting effect on the programmed cell death process, which also prevents pathogenesis [17]. The results of several clinical trials suggest an association between the amount of lutein found in food and a reduction in the risk of AMD [17,18]. In recent times, more and more attention has been paid to the analysis of the effect of lutein on the pathogenesis of AMD in experimental studies. Moreover, the effect of lutein on the regulation of pyroptosis signaling pathways is still not fully understood.

Therefore, in this study, we determined the expression profile of pyroptosis-related genes in the human retinal pigment epithelial cell line ARPE-19 exposed to lutein and under conditions of oxidative stress induced by hydrogen peroxide (H₂O₂). However, it is worth mentioning that ARPE-19 cells stand as a non-ideal model of primary RPE cells due to some differences between these cells, such as gene expression, phenotype, and possible chromosomal abnormalities, among others [19].

Nevertheless, the ARPE-19 cell line has been used in numerous studies, not least because the ARPE-19 gene expression pattern for apoptosis is quite similar to that of native RPE cells [3,20,21].

2. Materials and Methods

2.1. Cell Culture Conditions and ARPEs-19 Viability Assessment

Human retinal pigment epithelial cells (ARPE-19, ATCC^® CRL-2302; Manassas, VI, USA) were routinely maintained at 37 °C in a 5% CO₂ incubator (Direct Heat CO₂; Thermo Scientific, Waltham, MA, USA) with the use of a DMEM-F12 (Dulbecco’s Modified Eagle’s Medium, Lonza, Basel, Switzerland), supplemented with 10% fetal bovine serum (EuroClone). The ARPE-19 cells used in the experiments were from passage 24. Both the cell number and viability were monitored by cell counting in the automated cell counter TC20 (BioRad, Hercules, CA, USA) after staining them with 0.2% trypan blue (Sigma-Aldrich, St. Louis, MO, USA). All the experiments were performed using cells that were approximately 80% confluent.

The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay (Sigma-Aldrich, St. Louis, MO, USA) was used to determine the influence of hydrogen peroxide (H₂O_2, Sigma-Aldrich, St. Louis, MO) and lutein (Sigma-Aldrich, St. Louis, MO) on the ARPEs’ viability. The ARPE-19 cells were treated with different H₂O₂ concentrations (100; 200; 300; 400 and 500; 1000; 2000 µM) in the medium at 37 °C for 30, 60, and 120 min. For the lutein, the cells were incubated with different concentrations (0.1, 0.5, 1.5, and 10 µM) for 24 h to measure possible cytotoxicity. The controls were left untreated. After respective experimental treatment, cell viability was determined by MTT assay.

MTT (1 mg/ mL) was added to the medium for 3 h (37 °C). After aspirating the MTT, the formazan crystals were dissolved in 100 μL of dimethyl sulfoxide (Sigma-Aldrich Louis, MO, USA). The absorbance was measured at the wavelength of 540 nm with the use of a microplate reader Wallac 1420 VICTOR (Perkin Elmer, Waltham, MA, USA).

2.2. ARPE-19 Cells Treatment

The concentrations of H₂O₂ and lutein were chosen experimentally and on the basis of available literature data [22]. The ARPE-19 cells were seeded into 6-well culture plates (Thermofisher, Waltham, Ma, USA) at a density of 5 × 10⁴/cm². The next day, the cells were treated with 1.0 µM of lutein for 24 h and 400 µM H₂O₂ for 1 h. H₂O₂ was added to the cultures 30 min prior to the lutein treatment. In separate cultures, the cells were incubated with lutein or H₂O₂ alone at the indicated concentrations and for the indicated time. The untreated cells served as a negative control. Each variant of the experiment was performed in six biological replications.

For the assessment of the mRNA level of the pyroptosis genes, the cells were lysed with the use of TRIzol (Invitrogen Life Technologies, Carlsbad, CA, USA) and then stored at −80 °C for 48 h until further molecular analysis.

2.3. Senescence Assay

The senescence of the ARPE-19 cells was examined using the Senescence Cells Histochemical Staining Kit (Sigma-Aldrich, St. Louis, MO, USA)—senescence-associated β-galactosidase (SA-β-gal), according to the manufacturer’s instructions. SA-β-gal-stained ARPE-19 cells were photographed at 200× magnification.

The number of SA-β-gal-positive (blue) cells versus the number of total ARPE-19 cells in the ten microscopic fields to calculate the percent of SA-β-gal-positive cells was counted. The values obtained from at least three independent experiments were averaged and the data are presented as the mean ± standard deviation.

2.4. Ribonucleic Acid Extraction

The total RNA was extracted using a TRI Reagent (Sigma-Aldrich, St. Louis, MO, USA), according to the manufacturer’s instructions. Purification was performed using the RNeasy Mini Kit (Qiagen Inc., Hilden, Germany, Cat. No. 74106) using columns and DNase I (RNase-Free DNase Set, Qiagen Inc., Hilden, Germany, Cat. No. 79254).

The extracted total RNA was qualitatively and quantitatively evaluated. In the qualitative assessment, the technique of electrophoresis in 1% agarose gel dyed with SimplySafe (EurX, Gdansk, Poland) was used. Quantitative evaluation of the isolated total RNA was performed by spectrophotometric measurement using a MaestroNano MN-913 nano spectrophotometer (MaestroGen Inc., Las Vegas, NV, USA).

2.5. Oligonucleotide Microarray Analysis

Evaluation of the changes in the expression profile of pyroptosis-related genes in the analyzed cells was carried out using the oligonucleotide microarray method. For this purpose, the HG-U133A 2.0 plate set (Affymetrix, Santa Clara, CA, USA) was used in accordance with the manufacturer’s recommendations.

In order to prepare the matrix for the analysis in the first step, cDNA synthesis was carried out with the SuperScript^® Choice System kit (Invitrogen Life Technologies, Waltham, MA, USA). In turn, the BioArray HighYield RNA Transcript Labeling Kit (Enzo Life Sciences, Inc, Farmingdale, NY, USA) was used to obtain biotinylated cRNA. Next, the labeled cRNA were subjected to a fragmentation step using the Sample Cleanup Module kit (Qiagen GmbH, Hilden, Germany). This process was carried out for 35 min at 94 °C. Hybridization of the cRNA to HG-U133A microarrays labeled with a phycoerythrin-streptavidin complex was the final step of the analysis. The scanning was performed using a GeneArray Scanner G2500A (Agilent Technologies, Inc., Santa Clara, CA, USA).

2.6. Quantitative Real-Time Polymerase Chain Reaction Assay

The mRNA levels of TXNIP, CXCL8, BCL2, BAX, CASP1, and CASP9 genes in the ARPE-19 cells treated with lutein under conditions of H₂O₂-induced oxidative stress were assessed using real-time RT-qPCR reactions. The mentioned genes were selected based on a previous microarray analysis and on the available literature data [17,18,19]. In addition, to confirm cellular senescence, the expression of the p53, CDKN1A, and CDKN1B genes were also analyzed. A Sensi-Fast™ reagent kit (Bioline, London, UK) was used for the reactions, as well as pairs of complementary primers (Forward and Reverse), the sequences of which are shown in Table 1. The real-time RT-qPCR reaction was performed using a LightCycler^® 480 System apparatus (Roche, Basel, Switzerland) and carried out with the following thermal conditions: reverse transcription 45 °C for 10 min, initial denaturation at 95 °C for 2 min, and then 45 cycles, including: denaturation 95 °C for 5 s, annealing at 60 °C for 10 s, and elongation at 72 °C for 5 s. All the samples were tested in triplicate.

ACTB mRNA expression assessment was used as a positive control of amplification. The assessment of the specificity of the reaction was made by analyzing the melting point of the PCR products and electrophoresis in 2% agarose gel.

The mRNA copy number was determined based on a standard curve method described previously by Strzalka-Mrozik et al. [23].

2.7. Bioinfromatics Analysis

The data obtained from the oligonucleotide microarrays were analyzed using the PL-Grid Infrastructure (http://www.plgrid.pl/; accessed on 21 September 2022). The GeneSpring 13.0 platform (Agilent Technologies UK Limited, South Queensferry, UK) database was used.

Bioinformatic analysis of the selected pyroptosis-related genes at the protein level was carried out using the STRING online database (https://string-db.org/; accessed on 20 October 2022). An interaction score of >0.4 was selected as the cutoff threshold. The results of protein–protein interactions were presented graphically.

2.8. Statistical Analysis

Statistical analysis was performed using STATISTICA 13.3 software (TIBCO Software Inc., Palo Alto, CA, USA). The number of mRNA copies of each gene was recalculated per µg of total RNA. The results of statistical significance were considered those with p < 0.05. The qualitative data were presented as mean ± standard deviation (SD) and graphically as a box plot. The W Shapiro–Wilk test was performed to determine the type of distribution. Comparisons of the quantitative variables between the study groups were evaluated using Student’s t-test and a one-way ANOVA with a Benjamini–Hochberg correction test. Dunnett’s and Tukey’s post hoc tests were also applied.

3. Results

3.1. ARPE-19 Viability Assessment

The H₂O₂ concentrations between 100 and 500 μM did not reduce ARPE-19 cell viability below 70% after 30, 60, and 120 min. However, there were statistically significant changes in the ARPE-19 cell viability after exposure to H₂O₂ between 400 and 2000 μM after all treatment times (Figure 1a).

The cytotoxicity assay of the lutein effect (in concentrations between 0.1 and 1.0 μM for 24 h) on the viability of the ARPE-19 cells showed no statistically significant differences compared to the control, thus confirming that lutein is not cytotoxic at the tested concentrations for the ARPE-19 cells. The higher studied concentrations (5 and 10 μM) of lutein caused a significant reduction of cell viability on average by 9% and 18%, respectively (Figure 1b).

For further analysis, H₂O₂ at the concentration of 400 µM and the treatment time of 60 min and lutein at the concentration of 1.0 µM and the treatment time of 24 h were selected.

3.2. Cellular Senescence of ARPE-19 Assessment

Cellular senescence was confirmed based on the significant level of SA-β-gal staining (Figure 2). The ARPE-19 cells were stained for senescence-associated β-galactosidase (SA-β-gal) activity. The H₂O₂-treated cells were stained strongly with SA-β-gal compared to the control cells. The percentage of SA-β-gal-positive ARPE-19 cells was 64.9 ± 8.4% in the H₂O₂ treated cells, whereas it was 14.6 ± 2.4% in the non-treated ARPE-19 cells (Figure 3).

Next, the mRNA levels of the cellular senescence markers (TP53, CDKN1A, and CDKN1B) were determined using the RT-qPCR technique. There was a statistically significant increase in the expression of TP53 in the H₂O₂-treated cells compared to the control cells (Student’s t-test; p = 0.021). However, there were no statistically significant changes in CDKN1A expression. In turn, the level of CDKN1B expression decreased statistically significantly due to the action of the hydrogen peroxide (Student’s t-test; p = 0.003) (Figure 4).

3.3. Differential Expression of Pyroptosis-Related Genes Based on Oligonucleotide Microarrays

During the next step of the research, the expression of pyroptosis-related genes was compared using the oligonucleotide microarray technique between the following groups: untreated control ARPE-19 cells (C), lutein-treated ARPE-19 cells (L), H₂O₂-treated ARPE-19 cells (H), and lutein- and H₂O₂-treated ARPE-19 cells (LH).

The typing of differentiating genes was performed on a panel of 428 probes for pyroptosis genes obtained from the GeneCards website (https:/www.genecard.org; accessed on 6 October 2022) and from previous studies [24,25]. The selected 239 pyroptosis-related genes are listed in Table S1 in the supplementary materials.

Among them, 128 statistically significant and differentially expressed transcripts were revealed (one-way ANOVA with the Benjamini–Hochberg correction test; p < 0.05).

The nature of the intergroup changes was determined using Tukey’s post hoc multiple comparison test (p < 0.05). All the groups were then compared in turn (Table 2).

The differentiation of pyroptosis-related genes between the studied groups was also assessed using the analysis heat map from the GeneSpring XG (Figure 5). Based on the color change of the fluorescence signals, the change in the expression of the studied genes was assessed, where the increase in expression was indicated by a color change toward red and the decrease in expression was indicated by a change toward blue.

A different color pattern was observed in each of the heat maps, thus confirming that the gene expression profile differed in each group.

Subsequently, the genes showing altered expression in the analyzed intergroup were further characterized. The determination of the multiplicity of the gene expression changes was enabled by the fold change parameter (FC), indicating the log2 of the difference in fluorescence signals between the subgroups studied and the direction of the observed change.

Overall, 18 mRNA IDs that had more than a two-fold statistically significant change in expression in at least one pair were determined in this analysis (Table 3).

Of these, seven transcripts were differentially expressed both in the H₂O₂-treated ARPE-19 cells versus the controls, and the lutein/H₂O₂-treated ARPE-19 cells versus the H₂O₂-treated cells (FC > 2.0).

3.4. Differential Expression of Pyroptosis-Related Genes Based on Real-Time RT-qPCR

The results obtained from the microarray analysis were also validated using an RT-qPCR reaction. For this purpose, two genes were selected for further analysis: TXNIP and CXCL8, associated with pyroptosis in ARPE-19 cells, with the highest FC. The BCL2, BAX, CASP1, and CASP9 genes were also analyzed (selected based on the literature) [26,27,28].

The level of changes in the expression of pyroptosis-related genes in the ARPE-19 cells exposed to the test compounds, with statistical significance marked, are presented in Figure 6.

Depending on the lutein or H₂O₂ used or the co-treatment of cells with both compounds, a statistically significant difference in the genes’ expression of TXNIP, CXCL8, BAX, and CASP1 (p < 0.05) was observed. However, no statistically significant difference was observed for BCL2 and CASP9.

For the ARPE-19 cells treated with lutein (L), a post hoc test showed a statistically significant difference in the TXNIP gene expression between the lutein-treated cells versus the control (C) (p < 0.001), as well as between the H₂O₂ vs. lutein-treated cells (p = 0.032).

The analysis of the CXCL8 gene showed a statistically significant difference between C versus L (p < 0.001) and between L versus cells co-treated with H₂O₂ and lutein at p = 0.001. Additionally, a statistically significant difference was observed in the BAX and CASP1 gene expressions between the L and H₂O₂ groups (p = 0.027 and p = 0.026, respectively). In the case of the BAX gene, there was also a change in expression among the control cells and the lutein-treated cells (p = 0.025).

In addition, the H₂O₂-treated cells showed a difference in the expression of TXNIP and CXCL8 genes at p < 0.001 between cells not treated with compounds and those treated with hydrogen peroxide.

Co-treatment with lutein and H₂O₂ (LH) of the tested cells resulted in a statistically significant change only in the expression of the CXCL8 gene as described above, and in the TXNIP gene between the C versus LH groups (p < 0.001).

3.5. Bioinformatic Analysis Using the String Database

Based on the bioinformatic analysis using the STRING database, the protein–protein interaction results of the selected pyroptosis-related genes were obtained. A network of probable protein–protein interactions consisting of 30 edges and 15 nodes was thus obtained (p < 0.001, mean confidence = 0.4). The results of the network of analyzed interactions are presented in Figure 7.

4. Discussion

Age-related macular degeneration is a multifactorial disease that occurs in the elderly and its pathogenesis remains largely elusive [1]. It initially affects the RPE, a monolayer of pigmented and polarized central nervous system (CNS) tissue and, over time, leads to a secondary loss of photoreceptor cells [6,7,29].

It should be emphasized that RPE cells play a key role in maintaining retinal homeostasis but are exposed to damaging factors throughout their lives, mainly related to oxidative stress. In addition, structures such as the thickness of Bruch’s membrane or choroid play an important role in AMD pathology [4,5]. Moreover, as a result of aging, more and more oxidative damage occurs in these cells, and consequently, they degenerate [6,7]. Under the influence of adverse factors, these cells can embark on a pathway of programmed death in which various genes and proteins are involved [8,12,30]. In the case of AMD, it has been suggested that it is related to the formation of the NLRP3 inflammasome, which is involved in cleaving gasdermin and setting the cell on the path of pyroptosis [8,12,30]. Many genes are involved in this process, and their proteins have a direct or indirect role in cleaving GSDMD, which is an inducer of pyroptosis [14]. In the course of AMD, inflammation is also observed, mainly due to increased amounts of pro-inflammatory cytokines, chiefly IL-1β and IL-8, which also play a role in leading the cells into the path of pyroptosis [14]. Since oxidative stress greatly affects the level of damage to retinal cells, new methods are needed to prevent the harmful effects of ROS on these cells [6,8]. An example of such a compound, which has natural antioxidant properties, is lutein [31,32]. In addition, it has anti-inflammatory properties and absorbs blue visible light within a 400–500 nm range, which promotes its use in the prevention of AMD [31,32,33]. Moreover, studies suggest that the combination of lutein and zeaxanthin has a positive effect on reducing the incidence of AMD [32,34].

The primary goal of this study was to evaluate changes in the expression of pyroptosis-related genes in senescent ARPE-19 cells after lutein treatment. As the expression pattern of the gene characteristic of apoptosis in ARPE-19 cells is similar to native RPE cells, it was decided that this research model would be used [20,21,22]. The concentration of the compound used did not have a statistically significant cytotoxic effect. Furthermore, cell senescence was induced by culturing the cells in the presence of H₂O₂, which was simultaneously assessed by SA-β-gal staining. The percentage of SA-β-gal-positive ARPE-19 cells was shown to be approximately 65%. We considered such a percentage of aged cells sufficient to continue the study. We also evaluated the expression of some genes for cellular senescence—i.e., p53, CDKN1A, and CDKN1B using real-time RT-qPCR [35].

Next, we performed a transcriptome analysis using Affymetrix HG-U133A 2.0 oligonucleotide microarrays, which revealed 128 differentiating genes associated with pyroptosis. We narrowed down the obtained genes to FC > 2.0 and obtained seven genes. For further analysis, we selected two of them with the highest FC ratios. In addition, four genes were selected based on the literature data. The selected genes were validated at the mRNA level using a real-time RT-qPCR reaction and in four groups: H₂O₂-treated cells, lutein-treated cells, co-treated cells, and non-treated cells, which were the control. In the next step, a bioinformatic analysis was carried out in the STRING database, which revealed the possible protein–protein interactions of the selected genes from oligonucleotide microarrays.

4.1. Altered Expression of p53, CDKN1A, and CDKN1B Genes as Additional Confirmation of Cellular Senescence in ARPE-19 Cells

To verify whether the cells actually senesced under the influence of H₂O₂, we performed the previously mentioned SA-β-Gal staining assay and evaluated the change in the expression levels of p53, CDKN1A, and CDKN1B genes in non-treated and H₂O₂-treated ARPE-19 cells. We observed a statistically significant increase in the expression of the p53 gene. This gene is mainly involved in cell cycle regulation and is also responsible for the process of apoptosis or cell senescence [35,36]. Zhuge et al. [37], assessing the effect of fullerenol on RPE cells, also used the p53 gene as a marker of senescence. They demonstrated that the compound reduced the expression level of the p53 gene, which is essential for cell senescence. The mRNA level of the CDKN1A (cyclin-dependent kinase inhibitor 1A) gene, also known as p21^WAF1, was not statistically significantly altered under the influence of H₂O₂. The role of p21 in senescence was investigated by the team of Dulić et al. [38] using human fibroblasts. The researchers showed that, although this gene is strongly correlated with p53, its levels can vary depending on the number of cell passages. In our study, where the senescent was performed by H₂O₂ instead of by passaging, a lack of change in the expression of this gene was found. This may be due to the fact that p21^WAF1/CIP1 expression is not maintained in senescent cells and is mainly required for the induction of senescence, as reported by Kumari and Jat [36].

To verify cellular senescence, we also evaluated the CDKN1B (cyclin-dependent kinase inhibitor 1B) gene at the mRNA level, which is known as p27^KIP1. It plays a key role in the control of apoptosis, cell cycle, and cell differentiation. The role of p27 in cellular senescence was also investigated by the team of Xu et al. [39] using mesenchymal stromal cells. They demonstrated that the induction of aging by passaging can contribute to a decrease in p27 levels, which they also linked to the similar expression of β-catenin—a major effector in the Wnt pathway. Also, they observed that with cellular senescent, an increase in the gene expression of p21 and p53, among other genes, occurs while p27 decreases, which we also demonstrated in our study however, with no change in the p21 gene expression. Thus, this suggests that the cells were senesced under the influence of H₂O₂.

Depending on the compound used, the expression of the genes TXNIP, CXCL8, BAX, BCL2, CASP1, and CASP9 in the ARPE-19 cells differed. Liu et al. [40] conducted a similar study in 2017, where, after treating ARPE-19 cells with the same test compounds, they evaluated an increase in the expression of genes by an RT-qPCR reaction, encoding cytokines such as TNF-α, IL-6, and IL-8 associated with inflammatory processes involved in the pathogenesis of AMD. In addition, they showed that hydrogen peroxide and lutein at concentrations >10 µM affect inflammation by upregulating the aforementioned genes [40]. The fact that we carried out the analysis using advanced molecular biology techniques, such as oligonucleotide microarrays, is particularly noteworthy in our work. Due to these techniques, the selected pyroptosis-related genes underwent increased expression after lutein and H₂O₂ treatment. In particular, oligonucleotide microarrays and RNA-Seq are the best methods for whole transcriptome gene expression profiling in toxicogenomic studies [41].

4.2. Effect of The Tested Compounds on the Expression of TXNIP as a Key Gene Involved in the Process of Pyroptosis

Thioredoxin-interacting protein (TXNIP) plays a key role in the formation of the NLRP3 inflammasome involved in the dysregulation of cell mitochondrial function. It also contributes to the generation of reactive oxygen species [42]. The mechanism of TXNIP is the inhibition of thioredoxin activity, consequently leading to the accumulation of ROS. However, small amounts of thioredoxin are required to refill the total pool of reduced glutathione involved in the antioxidant system [43,44]. In our study, using a real-time RT-qPCR reaction, we found a decrease in the mRNA copy number of the TXNIP gene in the ARPE-19 cells after treating them with hydrogen peroxide, lutein, and a co-treatment with both compounds. Therefore, this may suggest that oxidative stress induced by H₂O₂ affects the reduction of TXNIP gene expression in ARPE-19 cells. In addition, interestingly, lutein, with potential protective effects, caused a similar effect. This is because lutein increases the expression of the Nrf2 gene, which indirectly contributes to the increase in reduced glutathione by refilling its pool [16]. In addition, the decrease in TXNIP gene expression may be related to the lack of appearance of the NLRP3 inflammasome in cells. Cells co-treated with both compounds also led to a decrease in TXNIP expression. A similar study was conducted by Ji Cho et al. [44]. They evaluated the effect of oxidative stress on ARPE-19 lines with pLVX-EF1α-IRES-Puro lentiviral vector-induced TXNIP gene overexpression. Using an RT-qPCR reaction, they observed that H₂O₂ applied as an oxidative stress stimulator reduced the expression level of the TXNIP gene, which was also observed in our study. Additionally, it should be noted that until now, the effect of lutein on the TXNIP expression on ARPE-19 cells has not been studied. Therefore, our study will introduce new information on the effect of this compound on a key gene, such as TXNIP, in the formation of the NLRP3 inflammasome.

4.3. Change in CXCL8 Gene Expression as a Key Pro-inflammatory Cytokine Exposed to the Tested Substances

Undoubtedly, one common group of proteins associated with inflammation is cytokines, where interleukins are the largest group [45,46]. Due to their biological functions, they can be either pro-inflammatory or anti-inflammatory. In the case of AMD, a key role is attributed to the C-X-C motif chemokine ligand 8 (CXCL8) gene encoding IL-8, which is classified as a pro-inflammatory cytokine [45,46]. During retinal degeneration, increased amounts of ROS occur, which results in the activation of the immune system associated with inflammation. IL-8, as a common pro-inflammatory cytokine, participates in this process [46]. Our study showed significant changes in the level of mRNA of the CXCL8 gene in ARPE-19 cells depending on the compound used.

An increase in the expression of this gene was observed in the H₂O₂-treated cells compared to the untreated cells. This suggests, therefore, that in situations of oxidative stress associated with the accumulation of ROS, genes encoding pro-inflammatory cytokines are activated. That fact is supported by a study by Yang et al. [46], which, using molecular biology and western blot techniques, assessed the level of gene expression and cytokine secretion after inducing oxidative stress with H₂O₂ and TGF-β2 of ARPE-19 cells. Interestingly, in our study, a similar effect was observed after treating the cells with lutein. This suggests that at this concentration, it may have an effect comparable to hydrogen peroxide. A key observation was noted in the case of ARPE-19 cells treated with H₂O₂ to induce oxidative stress and simultaneous treatment with lutein at a concentration of 1.0 µM. In this case, there was a significant decrease in the mRNA copy number of the CXCL8 gene. This suggests that lutein abolishes the effect of H₂O₂, thus inhibiting the formation of ROS. To date, the effect of lutein on the CXCL8 level in ARPE-19 cells has not been studied, but Kim et al. [47] conducted a similar study. In a study on human gastric epithelial cell lines treated with H₂O₂ conducted earlier in the experiment, they examined the simultaneous effects of β-carotene and lutein on IL-8 expression and secretion [47]. The molecular analysis using real-time RT-qPCR and enzyme-linked immunosorbent assay (ELISA) proved that the combination of the two compounds has an inhibitory effect on H₂O₂, affecting the reduction of IL-8 secretion by impacting the suppression of the transcription factor NF-κB [47]. A decrease in CXCL8 expression under the influence of lutein was also observed in our study on ARPE-19 cells.

4.4. Effect of the Studied Compounds on APRE-19 Cells in Reference to the Genes Involved in the Process of Apoptosis

Some of the important genes involved in the process of cell death by apoptosis are the BAX (BCL2-associated X protein) and BCL2 (B-cell lymphoma) genes [48]. BAX is a pro-apoptotic protein that can induce either apoptosis or pyroptosis during stress factors, such as chemotherapy. The activation of the BAK/BAX pathway causes activation of the caspase cascade due to the occurrence of the mitochondrial outer membrane permeabilization (MOMP) effect [49]. The pathway to which the cell will be activated subsequently depends on BAX-activated caspases, which will turn the cell on the pyroptosis pathway when gasdermin E (GSDME) is cleaved [49]. In our own studies conducted on ARPE-19 cell lines, the level of BAX gene expression changes depending on the compound used, and was investigated using oligonucleotide microarrays, as well as real-time RT-qPCR reaction. It was observed that the mRNA copy number of this gene did not change statistically significantly when H₂O₂, a strong stimulator of oxidative stress, was applied, as well as when the combination of lutein and H₂O₂ was used. Interestingly, a statistically significant decrease in the amount of the BAX gene was noted in the lutein-treated ARPE-19 cells, which may suggest that this compound indirectly affects the process of apoptosis or pyroptosis in cells, but this requires further study. Hu et al. [49] carried out a similar study, however, on cells of different neoplastic lines. Using flow cytometry and western blot analysis, they demonstrated that the application of chemotherapy induces the occurrence of pyroptosis in cells through the BAK/BAX-caspase 3-GSDME pathway. Interestingly, they also concluded that single proteins of BAK and BAX are able to independently contribute to the development of pyroptosis. In our own study, using molecular biology techniques, we found that the level of BAX gene expression in ARPE-19 cells does not change statistically significantly.

BCL2, on the other hand, belongs to a group of anti-apoptotic proteins, whose function is to bind to the pro-apoptotic proteins BAX and BAK, limiting their oligomerization and contributing to the inhibition of apoptosis [50]. In a study conducted by Shi et al. [50] on cells of the neoplastic lines HT-29 and THP-1 using immunoblotting and immunoprecipitation, the researchers found that the BCL2 protein negatively affected the NLRP3 inflammasome. In addition, they showed that the protein inhibits the cleavage of GSDMD by caspases, resulting in a reduction in the entry of cells into the pyroptosis pathway [48]. In our own study on ARPE-19 cells treated with H₂O₂ and lutein, no changes in BCL2 gene expression were observed. This suggests, therefore, that these compounds do not significantly affect the mRNA level of this gene, and thus, probably do not affect the development of pyroptosis in cells associated with the BCL2 gene.

4.5. Expression of Caspase-1 and Caspase-9 mRNA in ARPE-19 Cells Treated with Test Compounds

Caspases, whose main function is to cleave GSDMD, certainly play an important role in the development of pyroptosis. This leads to the onset of pyroptosis, which is characterized by the occurrence of inflammation preceded by the activation of interleukins, mainly IL-1β and IL-18 [51,52,53]. A key function in this footnote is played by caspase-1 (CASP1), which is activated by inflammasomes [51]. In a study conducted by Tseng et al. [54] on eye tissue sections taken from patients with geographic atrophy or neovascular AMD, as well as the ARPE-19 cell line, they investigated the effect of lysosomal destabilization on NLRP3 inflammasome activation. Through the immunohistochemical technique and an RT-qPCR reaction, they proved that there is an increase in the NLRP3 inflammasome in AMD. In addition, lysosomal destabilization caused the activation of caspase-1, which induced a pyroptosis effect on the cells. In our own study on ARPE-19 cells, an increase in CASP1 mRNA was observed in cells treated with H₂O₂ compared to the controls, but the increase was not statistically significant. Interestingly, a decrease in CASP1 expression was observed in cells treated with lutein, which may indicate that this compound has a protective effect on the cells, as it decreases the expression of caspase-1, which is key to inducing the pyroptosis effect.

Caspase-9 (CASP9) also plays an important role in the process of programmed cell death [52]. It is a cysteine-aspartate protease whose role is to initiate intrinsic apoptosis. In addition, changes in CASP9 expression levels are observed in many diseases including retina-related eye diseases, and caspase-9 is also indirectly associated with CASP3/GSDME [52,55,56]. In a study conducted by Lu et al. [57] on lung cancer samples from patients, as well as cell lines and an animal model, they evaluated the effects of selected antitumor drugs on various forms of cell death. They used immunohistochemical methods, electron microscopy, and analysis at the protein level using western blot techniques. In their experiment, they concluded that caspase-9 participates in the stimulation of apoptosis in cells, which in turn activates the caspase-3/GSDME pathway and leads cells into the pyroptosis pathway [57]. Our studies on ARPE-19 cells treated with hydrogen peroxide and lutein did not observe significant statistical changes in the level of CASP9 expression. This suggests, therefore, that the tested compounds probably do not affect the entry of cells into the apoptosis or pyroptosis pathway mediated by caspase-9. However, this requires further research.

It should be noted that although ARPE-19 cells are similar to normal RPE cells in terms of morphology and the expression of some genes, they have limitations [57,58]. In a study by Ablonczy et al. [59], the researchers showed that ARPE-19 cells have reduced expression of some key markers that characterize RPE cells in vivo. APRE-19 cells have lower expression of the RPE65 marker and cellular retinaldehyde-binding protein (CRALBP), components that are essential for the normal pattern cycle in RPE cells. In addition, there are different strengths of cellular connections compared to normal cells in vivo [59]. However, the researchers suggest that the cells of the ARPE-19 line have a morphology more similar to aging RPE or pathological cells. To elaborate, they could be used in studies of the effects of exogenous substances to reverse pathologic changes. Therefore, these differences should be taken into account when planning an experiment, and the appropriate model for the study should be chosen [58,59].

In summary, through the techniques of molecular biology, we demonstrated the effect of the studied compounds on the expression levels of pyroptosis-related genes (Table S2 in the supplementary materials).

Knowledge of the effect of lutein on the expression of genes in ARPE-19 cells may be useful for the development of new methods to prevent the activation of the pathway of programmed death called pyroptosis, which may result in a reduction in the number of events associated with AMD in the future. It should be noted that our results were obtained using in vitro experiments, which cannot be directly compared with in vivo studies.

5. Conclusions

Our results suggest that exposure to lutein of senescent retinal pigment epithelial cell line ARPE-19 changes in the level of transcriptional activity of pyroptosis genes. Investigating the influence of lutein on the transcriptional activity of these genes may provide additional information about the molecular mechanisms of their action. Moreover, lutein may have an effect on the processes activated by pyroptosis-related genes in different ways depending on the presence or absence of H₂O₂ induced oxidative stress.

It should be noted, however, that the effect observed for the cell line when tested in vitro may not be the same for an organ response in vivo. Moreover, our results should also be confirmed at the protein level. Because the number of studies on pyroptosis-related genes in AMD is limited, more research is needed.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/cimb45020097/s1. Table S1: Pyroptosis-related genes selected for oligonucleotide microarrays analysis; Table S2: The classification of selected pyroptosis-related genes with a description of their function based on the STRING database.

Author Contributions

Conceptualization, B.S.-M. and J.M.G.; methodology, C.K.-R. and J.A.; data analysis and interpretation, M.K.-D., C.K.-R. and B.S.-M.; investigation, J.A., C.K.-R. and B.S.-M.; writing—original draft preparation, B.S.-M., M.M. and N.K.; writing-review and editing, B.S.-M., M.M. and N.K.; supervision, B.S.-M. and J.M.G.; project administration, B.S.-M. and J.M.G.; funding acquisition B.S.-M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Medical University of Silesia, Katowice, Poland, based on decision no. PCN-1-036/N/1/F.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare no conflict of interest.

References

Ma, H.H.; Liutkevičienė, R. Age-related macular degeneration: What do we know so far? Acta Med. Litu. 2021, 28, 36–47. [Google Scholar] [CrossRef]
Sreekumar, P.G.; Su, F.; Spee, C.; Araujo, E.; Nusinowitz, S.; Reddy, S.T.; Kannan, R. Oxidative stress and lipid accumulation augments cell death in LDLR-deficient RPE cells and Ldlr^−/− mice. Cells 2022, 12, 43. [Google Scholar] [CrossRef]
Zhang, C.; Baffi, J.; Cousins, S.W.; Csaky, K.G. Oxidant-induced cell death in retinal pigment epithelium cells mediated through the release of apoptosis-inducing factor. J. Cell Sci. 2003, 116, 1915–1923. [Google Scholar] [CrossRef]
Farazdaghi, M.K.; Ebrahimi, K.B. Role of the choroid in age-related macular degeneration: A current review. J. Ophthalmic. Vis. Res. 2019, 14, 78–87. [Google Scholar]
Farinha, C.; Silva, A.L.; Coimbra, R.; Nunes, S.; Cachulo, M.L.; Marques, J.P.; Pires, I.; Cunha-Vaz, J.; Silva, R. Retinal layer thicknesses and neurodegeneration in early age-related macular degeneration: Insights from the coimbra eye study. Graefes Arch. Clin. Exp. Ophthalmol. 2021, 259, 2545–2557. [Google Scholar]
Nita, M.; Grzybowski, A. The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults. Oxid. Med. Cell. Longev. 2016, 2016, 3164734. [Google Scholar] [CrossRef]
Toma, C.; De Cillà, S.; Palumbo, A.; Garhwal, D.P.; Grossini, E. Oxidative and nitrosative stress in age-related macular degeneration: A review of their role in different stages of disease. Antioxidants 2021, 10, 653. [Google Scholar] [CrossRef]
Yang, M.; So, K.F.; Lam, W.C.; Lo, A.C.Y. Novel programmed cell death as therapeutic targets in age-related macular degeneration? Int. J. Mol. Sci. 2020, 21, 7279. [Google Scholar] [CrossRef]
Ruan, Y.; Jiang, S.; Gericke, A. Age-related macular degeneration: Role of oxidative stress and blood vessels. Int. J. Mol. Sci. 2021, 22, 1296. [Google Scholar] [CrossRef]
Chen, X.; Zhu, Y.; Shi, X.; Zuo, J.; Hu, T.; Wu, H.; Xia, Y.; Shi, W.; Wei, W. Ming-mu-di-huang-pill activates SQSTM1 via AMPK-mediated autophagic KEAP1 degradation and protects RPE cells from oxidative damage. Oxid. Med. Cell. Longev. 2022, 2022, 5851315. [Google Scholar] [CrossRef]
Fang, Y.; Tian, S.; Pan, Y.; Li, W.; Wang, Q.; Tang, Y.; Yu, T.; Wu, X.; Shi, Y.; Ma, P.; et al. Pyroptosis: A new frontier in cancer. Biomed. Pharmacother. 2020, 121, 109595. [Google Scholar]
Yabal, M.; Calleja, D.J.; Simpson, D.S.; Lawlor, K.E. Stressing out the mitochondria: Mechanistic insights into NLRP3 inflammasome activation. J. Leukoc. Biol. 2019, 105, 377–399. [Google Scholar] [CrossRef]
Kelley, N.; Jeltema, D.; Duan, Y.; He, Y. The NLRP3 inflammasome: An overview of mechanisms of activation and regulation. Int. J. Mol. Sci. 2019, 20, 3328. [Google Scholar] [CrossRef] [Green Version]
Gao, J.; Cui, J.Z.; To, E.; Cao, S.; Matsubara, J.A. Evidence for the activation of pyroptotic and apoptotic pathways in RPE cells associated with NLRP3 inflammasome in the rodent eye. J. Neuroinflamm. 2018, 15, 15. [Google Scholar]
Yang, M.; So, K.F.; Lo, A.C.Y.; Lam, W.C. The effect of lycium barbarum polysaccharides on pyroptosis-associated amyloid β_{1- 40} oligomers-induced adult retinal pigment epithelium 19 cell damage. Int. J. Mol. Sci. 2020, 21, 4658. [Google Scholar] [CrossRef]
Frede, K.; Ebert, F.; Kipp, A.P.; Schwerdtle, T.; Baldermann, S. Lutein activates the transcription factor Nrf2 in human retinal pigment epithelial cells. J. Agric. Food Chem. 2017, 65, 5944–5952. [Google Scholar] [CrossRef]
Li, L.H.; Lee, J.C.; Leung, H.H.; Lam, W.C.; Fu, Z.; Lo, A.C.Y. Lutein supplementation for eye diseases. Nutrients 2020, 12, 1721. [Google Scholar] [CrossRef]
Feng, L.; Nie, K.; Jiang, H.; Fan, W. Effects of lutein supplementation in age-related macular degeneration. PLoS ONE 2019, 14, e0227048. [Google Scholar]
Pfeffer, B.A.; Fliesler, S.J. Reassessing the suitability of ARPE-19 cells as a valid model of native RPE biology. Exp. Eye Res. 2022, 219, 109046. [Google Scholar]
Samuel, W.; Jaworski, C.; Postnikova, O.A.; Kutty, R.K.; Duncan, T.; Tan, L.X.; Poliakov, E.; Lakkaraju, A.; Redmond, T.M. Appropriately differentiated ARPE-19 cells regain phenotype and gene expression profiles similar to those of native RPE cells. Mol. Vis. 2017, 23, 60–89. [Google Scholar]
Alizadeh, M.; Wada, M.; Gelfman, C.M.; Handa, J.T.; Hjelmeland, L.M. Downregulation of differentiation specific gene expression by oxidative stress in ARPE-19 cells. Investig. Ophthalmol. Vis. Sci. 2001, 42, 2706–2713. [Google Scholar]
Muangnoi, C.; Phumsuay, R.; Jongjitphisut, N.; Waikasikorn, P.; Sangsawat, M.; Rashatasakhon, P.; Paraoan, L.; Rojsitthisak, P. Protective effects of a lutein ester prodrug, lutein diglutaric acid, against H₂O₂-induced oxidative stress in human retinal pigment epithelial cells. Int. J. Mol. Sci. 2021, 22, 4722. [Google Scholar]
Strzalka-Mrozik, B.; Stanik-Walentek, A.; Kapral, M.; Kowalczyk, M.; Adamska, J.; Gola, J.; Mazurek, U. Differential expression of transforming growth factor-beta isoforms in bullous keratopathy corneas. Mol. Vis. 2010, 16, 161–166. [Google Scholar]
Zhang, M.; Cheng, Y.; Xue, Z.; Sun, Q.; Zhang, J. A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration. BMC Cancer 2021, 21, 1311. [Google Scholar] [CrossRef]
Ye, Y.; Dai, Q.; Qi, H. A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer. Cell Death Discov. 2021, 7, 71. [Google Scholar] [CrossRef]
Chen, M.; Rong, R.; Xia, X. Spotlight on pyroptosis: Role in pathogenesis and therapeutic potential of ocular diseases. J. Neuroinflamm. 2022, 19, 183. [Google Scholar] [CrossRef]
Bardak, H.; Uğuz, A.C.; Bardak, Y. Protective effects of melatonin and memantine in human retinal pigment epithelium (ARPE-19) cells against 2-ethylpyridine-induced oxidative stress: Implications for age-related macular degeneration. Cutan. Ocul. Toxicol. 2018, 37, 112–120. [Google Scholar]
Du, Y.; You, L.; Ni, B.; Sai, N.; Wang, W.; Sun, M.; Xu, R.; Yao, Y.; Zhang, Z.; Qu, C.; et al. Phillyrin mitigates apoptosis and oxidative stress in hydrogen peroxide-treated RPE cells through activation of the Nrf2 signaling pathway. Oxid. Med. Cell. Longev. 2020, 2020, 2684672. [Google Scholar] [CrossRef]
Golestaneh, N.; Chu, Y.; Xiao, Y.Y.; Stoleru, G.L.; Theos, A.C. Dysfunctional autophagy in RPE, a contributing factor in age-related macular degeneration. Cell Death Dis. 2017, 8, e2537. [Google Scholar]
Celkova, L.; Doyle, S.L.; Campbell, M. NLRP3 inflammasome and pathobiology in AMD. J. Clin. Med. 2015, 4, 172–192. [Google Scholar] [CrossRef]
Choo, P.P.; Woi, P.J.; Bastion, M.C.; Omar, R.; Mustapha, M.; Md Din, N. Review of evidence for the usage of antioxidants for eye aging. Biomed. Res. Int. 2022, 2022, 5810373. [Google Scholar]
Mrowicka, M.; Mrowicki, J.; Kucharska, E.; Majsterek, I. Lutein and zeaxanthin and their roles in age-related macular degeneration-neurodegenerative disease. Nutrients 2022, 14, 827. [Google Scholar] [CrossRef]
Roberts, J.E.; Dennison, J. The photobiology of lutein and zeaxanthin in the eye. J. Ophthalmol. 2015, 2015, 687173. [Google Scholar] [CrossRef] [Green Version]
Li, S.S.; Wang, H.H.; Zhang, D. Efficacy of different nutrients in age-related macular degeneration: A systematic review and network meta-analysis. Semin. Ophthalmol. 2022, 37, 515–523. [Google Scholar]
Wang, S.; Wang, X.; Cheng, Y.; Ouyang, W.; Sang, X.; Liu, J.; Su, Y.; Liu, Y.; Li, C.; Yang, L.; et al. Autophagy dysfunction, cellular senescence, and abnormal immune-inflammatory responses in AMD: From mechanisms to therapeutic potential. Oxid. Med. Cell. Longev. 2019, 2019, 3632169. [Google Scholar]
Kumari, R.; Jat, P. Mechanisms of cellular senescence: Cell cycle arrest and senescence associated secretory phenotype. Front. Cell. Dev. Biol. 2021, 9, 645593. [Google Scholar]
Zhuge, C.C.; Xu, J.Y.; Zhang, J.; Li, W.; Li, P.; Li, Z.; Chen, L.; Liu, X.; Shang, P.; Xu, H.; et al. Fullerenol protects retinal pigment epithelial cells from oxidative stress-induced premature senescence via activating SIRT1. Investig. Ophthalmol. Vis. Sci. 2014, 55, 4628–4638. [Google Scholar]
Dulić, V.; Beney, G.E.; Frebourg, G.; Drullinger, L.F.; Stein, G.H. Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts. Mol. Cell. Biol. 2000, 20, 6741–6754. [Google Scholar] [CrossRef]
Xu, Y.; Tian, Y.; Tong, D.; Zhang, H.; Luo, Z.; Shang, X.; Dong, Y. Wnt signaling inhibits high-density cell sheet culture induced mesenchymal stromal cell aging by targeting cell cycle inhibitor p27. Front. Bioeng. Biotechnol. 2020, 8, 946. [Google Scholar] [CrossRef]
Liu, H.; Liu, W.; Zhou, X.; Long, C.; Kuang, X.; Hu, J.; Tang, Y.; Liu, L.; He, J.; Huang, Z.; et al. Protective effect of lutein on ARPE-19 cells upon H2O2-induced G2/M arrest. Mol. Med. Rep. 2017, 16, 2069–2074. [Google Scholar] [CrossRef]
Horstmann, C.; Davenport, V.; Zhang, M.; Peters, A.; Kim, K. Transcriptome profile alterations with carbon nanotubes, quantum dots, and silver nanoparticles: A review. Genes 2021, 12, 794. [Google Scholar] [CrossRef]
Devi, T.S.; Hosoya, K.; Terasaki, T.; Singh, L.P. Critical role of TXNIP in oxidative stress, DNA damage and retinal pericyte apoptosis under high glucose: Implications for diabetic retinopathy. Exp. Cell Res. 2013, 319, 1001–1012. [Google Scholar] [CrossRef]
Qayyum, N.; Haseeb, M.; Kim, M.S.; Choi, S. Role of thioredoxin-interacting protein in diseases and its therapeutic outlook. Int. J. Mol. Sci. 2021, 22, 2754. [Google Scholar] [CrossRef]
Cho, M.J.; Yoon, S.J.; Kim, W.; Park, J.; Lee, J.; Park, J.G.; Cho, Y.L.; Kim, J.H.; Jang, H.; Park, Y.J.; et al. Oxidative stress-mediated TXNIP loss causes RPE dysfunction. Exp. Mol. Med. 2019, 51, 1–13. [Google Scholar]
Kauppinen, A.; Paterno, J.J.; Blasiak, J.; Salminen, A.; Kaarniranta, K. Inflammation and its role in age-related macular degeneration. Cell. Mol. Life Sci. 2016, 73, 1765–1786. [Google Scholar] [CrossRef]
Yang, I.H.; Lee, J.J.; Wu, P.C.; Kuo, H.K.; Kuo, Y.H.; Huang, H.M. Oxidative stress enhanced the transforming growth factor-β2-induced epithelial-mesenchymal transition through chemokine ligand 1 on ARPE-19 cell. Sci. Rep. 2020, 10, 4000. [Google Scholar] [CrossRef]
Kim, Y.; Seo, J.H.; Kim, H. β-Carotene and lutein inhibit hydrogen peroxide-induced activation of NF-κB and IL-8 expression in gastric epithelial AGS cells. J. Nutr. Sci. Vitaminol. 2011, 57, 216–223. [Google Scholar] [CrossRef]
Maes, M.E.; Schlamp, C.L.; Nickells, R.W. BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells. Prog. Retin. Eye Res. 2017, 57, 1–25. [Google Scholar] [CrossRef] [Green Version]
Hu, L.; Chen, M.; Chen, X.; Zhao, C.; Fang, Z.; Wang, H.; Dai, H. Chemotherapy-induced pyroptosis is mediated by BAK/BAX-caspase-3-GSDME pathway and inhibited by 2-bromopalmitate. Cell Death Dis. 2020, 11, 281. [Google Scholar] [CrossRef]
Shi, C.S.; Kehrl, J.H. Bcl-2 regulates pyroptosis and necroptosis by targeting BH3-like domains in GSDMD and MLKL. Cell Death Discov. 2019, 5, 151. [Google Scholar] [CrossRef]
Pan, Y.; Cai, W.; Huang, J.; Cheng, A.; Wang, M.; Yin, Z.; Jia, R. Pyroptosis in development, inflammation and disease. Front. Immunol. 2022, 13, 5456. [Google Scholar] [CrossRef]
Zacks, D.N.; Kocab, A.J.; Choi, J.J.; Gregory-Ksander, M.S.; Cano, M.; Handa, J.T. Cell death in AMD: The rationale for targeting Fas. J. Clin. Med. 2022, 11, 592. [Google Scholar] [CrossRef]
Zhao, M.; Li, S.; Matsubara, J.A. Targeting pyroptotic cell death pathways in retinal disease. Front. Med. 2022, 8, 802063. [Google Scholar] [CrossRef]
Tseng, W.A.; Thein, T.; Kinnunen, K.; Lashkari, K.; Gregory, M.S.; D’Amore, P.A.; Ksander, B.R. NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: Implications for age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2013, 54, 110–120. [Google Scholar] [CrossRef]
Avrutsky, M.I.; Troy, C.M. Caspase-9: A multimodal therapeutic target with diverse cellular expression in human disease. Front. Pharmacol. 2021, 12, 701301. [Google Scholar]
Gao, L.; Jiang, Z.; Han, Y.; Li, Y.; Yang, X. Regulation of pyroptosis by ncRNA: A novel research direction. Front. Cell. Dev. Biol. 2022, 10, 840576. [Google Scholar] [CrossRef]
Lu, H.; Zhang, S.; Wu, J.; Chen, M.; Cai, M.C.; Fu, Y.; Li, W.; Wang, J.; Zhao, X.; Yu, Z.; et al. Molecular targeted therapies elicit concurrent apoptotic and GSDME-dependent pyroptotic tumor cell death. Clin. Cancer Res. 2018, 24, 6066–6077. [Google Scholar] [CrossRef]
Dunn, K.C.; Aotaki-Keen, A.E.; Putkey, F.R.; Hjelmeland, L.M. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp. Eye Res. 1996, 62, 155–169. [Google Scholar] [CrossRef]
Ablonczy, Z.; Dahrouj, M.; Tang, P.H.; Liu, Y.; Sambamurti, K.; Marmorstein, A.D.; Crosson, C.E. Human retinal pigment epithelium cells as functional models for the RPE in vivo. Investig. Ophthalmol. Vis. Sci. 2011, 52, 8614–8620. [Google Scholar] [CrossRef]

Figure 1. Cell viability of the ARPE-19 cells that were treated with (a) H₂O₂ for 30, 60, and 120 min., as well as (b) treated with lutein for 24 h. Each bar represents the mean ± standard deviation (SD), Dunnett’s test, * p < 0.05 versus control (C). Sample size: five wells and three technical replicates for each concetration of H₂0₂ and eight wells and three technical replicates for each concetration of lutein.

Figure 2. Non-treated and H₂O₂-treated ARPE-19 cells stained for senescence-associated β-galactosidase activity. The cells were treated with H₂O₂ at a concentration of 400 μM for 60 min. The arrows indicate blue SA-β-gal-positive cells.

Figure 3. Percentage of SA-β-gal-positive cells in non-treated (C) and H₂O₂-treated ARPE-19 cells (H). The bars present mean ± standard deviation (SD); Student’s t-test; * p < 0.05. The percent of SA-β-gal-positive cells was counted in ten microscopic fields.

Figure 4. Changes in the mRNA levels of (a) TP53, (b) CDKN1A and (c) CDKN1B genes in non-treated (C) and H₂O₂-treated (H) ARPE-19 cells. The box and whisker plots present the mean ± standard error (SE) and standard deviation (SD) of copy numbers per 1 μg of the total RNA; Student’s t-test; * p < 0.05 versus C. Sample size: three biological and three technical replicates for each test group.

Figure 5. Fluorescence signal intensity maps specific to 128 ID mRNA pyroptosis-related genes specific to the control ARPE--19 cells (C), lutein-treated ARPE-19 cells (L), H₂O_2--treated ARPE-19 cells (H), and lutein-- and H₂O₂-treated ARPE-19 cells (LH). Blue—indicates the lowest values and red—indicates the highest values of fluorescence signals.

Figure 6. Changes in the mRNA levels of (a) TXNIP, (b) CXCL8, (c) BCL2, (d) BAX, (e) CASP1, and (f) CASP9 genes in senescent retinal pigment epithelial cells after treatment with H₂O₂ (H), lutein (L), co-treated with lutein and H₂O₂ (LH), and non-treated cells (C). The box and whisker plots present the mean ± standard error (SE) and standard deviation (SD) of copy numbers per 1 μg of the total RNA; Tukey’s post hoc test; * p < 0.05 versus C; # p < 0.05 versus H; ^ p < 0.05 versus LH. Sample size—three biological and three technical replicates for each test group.

Figure 7. Protein–protein interaction network generated using the STRING database. STRING database—Search Tool for the Retrieval of Interacting Genes/Proteins.

Table 1. Primer sequences for amplification of TXNIP, CXCL8, BCL2, BAX, CASP1, CASP9, TP53, CDKN1A, and CDKN1B mRNAs.

Gene	Oligonucleotide Sequence	Amplimer Length (bp)	Tm (°C)
TXNIP	Forward: 5′CAGCCAACAGGTGAGAATGA3′ Reverse: 5′TTGAAGGATGTTCCCAGAGG3′	104	83.1
CXCL8	Forward: 5′CTCTAACTCTTTATATAGGAATT3′ Reverse: 5′GATTGATTTTATCAACAGGCA3′	203	81.2
BCL2	Forward: 5′GATTGTGGCCTTCTTTGAG3′ Reverse: 5′GTTCCACAAAGGCATCC3′	164	85.8
BAX	Forward: 5′CCTGTGCACCAAGGTGCCGGAACT3′ Reverse: 5′CCACCCTGGTCTTGGATCCAGCCC3′	99	84.4
CASP1	Forward: 5′CAACTACAGAAGAGTTTGAGG3′ Reverse: 5′AACATTATCTGGTGTGGAAG3′	92	82.0
CASP9	Forward: 5′CTCTACTTTCCCAGGTTTTG3′ Reverse: 5′TTTCACCGAAACAGCATTAG3′	148	84.4
TP53	Forward: 5′ACCTATGGAAACTACTTCCTG3′ Reverse: 5′ACCATTGTTCAATATCGTCC3′	99	83.7
CDKN1A	Forward: 5′ CAGCATGACAGATTTCTACC3′ Reverse: 5′CAGGGTATGTACATGAGGAG3′	200	88.4
CDKN1B	Forward: 5′ AACCGACGATTCTTCTACTC3′ Reverse: 5′ TGTTTACGTTTGACGTCTTC3′	133	84.7
ACTB	Forward: 5′TCACCCACACTGTGCCCATCTACGA3′ Reverse: 5′CAGCGGAACCGCTCATTGCCAATGG3′	295	88.4

bp—base pair; Tm—melting temperature.

Table 2. The number of probe set identifiers (IDs) differentiating the examined transcriptome groups from each other.

Tukey’s Post-Hoc Multiple Comparison Test
Transcriptome Group	IDs [L]	IDs [H]	IDs [LH]	IDs [C]
IDs [L]	–	112	28	3
IDs [H]	16	–	98	119
IDs [LH]	100	30	–	28
IDs [C]	125	9	100	–

[L]—lutein-treated ARPE-19 cells; [H]—H₂O₂-treated ARPE-19 cells; [LH]—lutein and H₂O₂-treated ARPE-19 cells; [C]—control; white—the number of mRNA IDs that differentiated the transcriptome groups; dark grey—the number of mRNA IDs in the comparative differentiation that is unrepresentative; light grey—the number of mRNA IDs that were representative of the differentiation of the transcriptome groups being tested; sample size: three biological replicates for each test group.

Table 3. Characteristics of pyroptosis-related genes, which had more than a two-fold statistically significant change in their expression in at least one pair.

Probe ID	Gene Symbol	p Value	FC
Probe ID	Gene Symbol	p Value	[H] vs. [C]	[H] vs. [LH]	[L] vs. [C]	[LH] vs. [C]
201008_s_at	TXNIP	p < 0.001	↓6.90	↓2.35	↓1.02	↓2.94
201009_s_at	TXNIP	p < 0.001	↓5.56	↓2.12	↓1.03	↓2.62
201010_s_at	TXNIP	p < 0.001	↓5.73	↓2.07	↓1.02	↓2.77
202269_x_at	GBP1	p < 0.001	↑2.06	↑1.19	↑1.03	↑1.73
202270_at	GBP1	p < 0.01	↑2.11	↑1.06	↓1.11	↑1.99
202859_x_at	CXCL8	p < 0.001	↑8.57	↑3.42	↑1.39	↑2.51
203685_at	BCL2	p < 0.001	↑2.30	↑2.40	↓1.11	↓1.04
204475_at	MMP1	p < 0.001	↑3.50	↑3.57	↓1.05	↓1.02
205207_at	IL6	p < 0.001	↑2.00	↑1.30	↑1.17	↑1.49
205234_at	SLC16A4	p < 0.01	↓2.05	↓1.83	↓1.17	↓1.12
206172_at	IL13RA2	p < 0.001	↑2.11	↑1.96	↓1.11	↑1.08
209395_at	CHI3L1	p < 0.01	↑1.71	↑2.17	↓1.09	↓1.27
209396_s_at	CHI3L1	p < 0.01	↑1.65	↑2.05	↓1.12	↓1.25
210538_s_at	BIRC3	p < 0.01	↑2.15	↑1.95	↑1.03	↑1.10
211506_s_at	CXCL8	p < 0.001	↑9.28	↑4.12	↑1.26	↑2.25
213700_s_at	PKM	p < 0.001	↓2.02	↓1.11	↓1.15	↓1.81
214657_s_at	NEAT1	p < 0.01	↓3.58	↓1.76	↓1.36	↓2.04
219209_at	IFIH1	p < 0.001	↓2.15	↓1.81	↑1.00	↓1.19

[C]—control; [L]—lutein-treated ARPE-19 cells; [H]—H₂O₂-treated ARPE-19 cells; [LH]—lutein- and H₂O₂-treated ARPE-19 cells; FC—fold change (FC > 2.0); ↑, ↓—higher and lower gene expression; ID—the probe set identifier; bold—genes that exhibit differential expression in the H₂O₂-treated ARPE-19 cells versus controls, and lutein-/ H₂O₂-treated ARPE-19 cells versus the H₂O₂-treated cells. Sample size: three biological replicates for each test group.

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Share and Cite

MDPI and ACS Style

Strzalka-Mrozik, B.; Madej, M.; Kurowska, N.; Kruszniewska-Rajs, C.; Kimsa-Dudek, M.; Adamska, J.; Gola, J.M. Changes in the Expression Profile of Pyroptosis-Related Genes in Senescent Retinal Pigment Epithelial Cells after Lutein Treatment. Curr. Issues Mol. Biol. 2023, 45, 1500-1518. https://doi.org/10.3390/cimb45020097

AMA Style

Strzalka-Mrozik B, Madej M, Kurowska N, Kruszniewska-Rajs C, Kimsa-Dudek M, Adamska J, Gola JM. Changes in the Expression Profile of Pyroptosis-Related Genes in Senescent Retinal Pigment Epithelial Cells after Lutein Treatment. Current Issues in Molecular Biology. 2023; 45(2):1500-1518. https://doi.org/10.3390/cimb45020097

Chicago/Turabian Style

Strzalka-Mrozik, Barbara, Marcel Madej, Natalia Kurowska, Celina Kruszniewska-Rajs, Magdalena Kimsa-Dudek, Jolanta Adamska, and Joanna Magdalena Gola. 2023. "Changes in the Expression Profile of Pyroptosis-Related Genes in Senescent Retinal Pigment Epithelial Cells after Lutein Treatment" Current Issues in Molecular Biology 45, no. 2: 1500-1518. https://doi.org/10.3390/cimb45020097

APA Style

Strzalka-Mrozik, B., Madej, M., Kurowska, N., Kruszniewska-Rajs, C., Kimsa-Dudek, M., Adamska, J., & Gola, J. M. (2023). Changes in the Expression Profile of Pyroptosis-Related Genes in Senescent Retinal Pigment Epithelial Cells after Lutein Treatment. Current Issues in Molecular Biology, 45(2), 1500-1518. https://doi.org/10.3390/cimb45020097

Article Menu